What is the Impact Factor of Blood Cancer Journal?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Blood Cancer Journal is 13.8, ranking in quartile Q1 of Web of Science (SCIE).

Is Blood Cancer Journal indexed in Web of Science or Scopus?

Yes, Blood Cancer Journal is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 4.307 (Q1) and an H-index of 94.

Who publishes Blood Cancer Journal and what is the Article Processing Charge (APC)?

Blood Cancer Journal is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $4,312 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Blood Cancer Journal?

The official ISO-4 abbreviation of Blood Cancer Journal is "BLOOD CANCER J" with common acronym "bcj". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #386Top JournalGold OA

Blood Cancer Journal

Acronym:bcj

•

Abbreviation (ISO):BLOOD CANCER J

•

Identifier (ISSN):2044-5385(Print)

•

Publisher:Springer Nature

Official Website Submission Portal Compare

Clarivate IF (2026)

13.8↑ +2.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Blood Cancer Journal

WoS Q1

Annual Impact Factor Metric

Current (2026):13.8

Scopus SJR & RankScopus Q1

4.307

#386

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

94 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate2.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

115articles/year

100% Gold OA•84.38% Original Research

Aims & Scope

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of particular interest include, but are not limited to, the following: Preclinical studies of new compounds, especially those that provide mechanistic insights Clinical trials and observations Reviews related to new drugs and current management of hematologic malignancies Novel observations related to new mutations, molecular pathways, and tumor genomics.

Topics Covered (Recognized by AI)

Medicine99.5%Biology99.3%Internal medicine97.1%Immunology93.9%Genetics84.7%Pathology61.9%Chemistry58.7%Biochemistry56.1%Cancer research49.2%Oncology49.1%Gene36.5%Surgery36.4%Leukemia32.6%Cell biology29.9%Psychology29.9%Multiple myeloma29.7%Psychiatry28%Hematology22.1%Bone marrow21.3%Lymphoma21.1%

Primary Research Areas

Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank6/103

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank24/333

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank7/103

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank29/333

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	6/103	Q1
ONCOLOGY	JCRSCIE	24/333	Q1
HEMATOLOGY	JCISCIE	7/103	Q1
ONCOLOGY	JCISCIE	29/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF13.8

Articles / Year173

Total Citations102

2025

IF11.6

Articles / Year230

Total Citations1,156

2024

IF12.9

Articles / Year224

Total Citations3,516

2023

IF12.8

Articles / Year194

Total Citations4,116

2022

IF9.812

Articles / Year173

Total Citations4,903

Year	Impact Factor	Articles / Year	Total Citations
2026	13.8	173	102
2025	11.6	230	1,156
2024	12.9	224	3,516
2023	12.8	194	4,116
2022	9.812	173	4,903
2021	11.037	203	11,491
2020	8.023	126	6,081
2019	7.895	103	4,121
2018	8.125	128	6,800
2017	—	142	6,801
2016	—	135	6,063
2015	—	110	6,264

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #386Scopus Q1SCImago Profile

Scopus Coverage:2011-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

4.307

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.92

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,312 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,972

3-Year Documents571

Citable Documents312

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate43.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Blood Cancer Journal (acronym: bcj, abbr: BLOOD CANCER J, ISSN: 2044-5385) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer Nature in England since 2011. The periodical holds a Journal Impact Factor (JIF) of 13.8, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 4.307 (Q1), an H-index of 94.

The journal enforces rigorous peer evaluation with an annual output of approximately 115 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,312 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.